Pills. Needles. Dyve. Dyve Bioscience’s mission is to legitimize the skin as a viable 3rd route of drug delivery, providing breakthrough topical therapy where oral or injectable dosage forms are unsuitable due to safety or pharmacokinetic issues. Our paradigm-shifting transdermal platform allows us to formulate a broad range of molecules without compromising pharmacokinetics. For more information, please visit www.dyvebio.com Corporate Contact Jim McGee Dyve Biosciences, Inc. 805-857-6449 jim.mcgee@dyvebio.com Investor Contact Corey Davis LifeSci Advisors, LLC 212-915-2577 cdavis@lifesciadvisors.com